Skip to content
  • Recurrent respiratory papillomatosis Africa
  • Recurrent respiratory papillomatosis Africa
rrpafricarrpafrica
  • Home
  • Pledge-a-thon
  • Practitioners
  • FAQ
  • Contact us
Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
30 September 2022

Abstract Abstract Aim of this study was to explore influence of the quadrivalent HPV vaccine [...]

Intersurgical interval increased with use of quadrivalent human papillomavirus vaccine (Gardasil) in a pediatric patient with recurrent respiratory papillomatosis: A case report
30 September 2022

Abstract This is a case of a 4 year old female with recalcitrant recurrent respiratory [...]

Therapeutic use of the HPV vaccine in recurrent respiratory papillomatosis: A case report
30 September 2022

Abstract Recurrent Respiratory Papillomatosis (RRP) is a condition characterized by recurring squamous papillomas in the [...]

Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: A systematic review and meta-analysis
30 September 2022

Background: Recurrent respiratory papillomatosis is a benign condition caused by human papillomavirus (HPV). Surgery is [...]

The role of HPV type in recurrent respiratory papillomatosis
30 September 2022

Objective: Human Papillomavirus (HPV) 6 and 11 are the aetiological agents responsible for Recurrent Respiratory [...]

HPV vaccines for treatment and prevention of recurrent respiratory papillomatosis
30 September 2022

Recurrent respiratory papillomatosis (RRP) is a disease of viral etiology and is caused by the [...]

Multi-year effect of human papillomavirus vaccination on recurrent respiratory papillomatosis
30 September 2022

Objective: To examine whether human papilloma virus (HPV) vaccination in combination with surgical resection could [...]

Global Market Study HPV
30 September 2022

Purpose & Background Several countries across regions and income groups have notified WHO of constraints [...]

A prospective study of the incidence of juvenile-onset recurrent respiratory papillomatosis after implementation of a national HPV vaccination program
30 September 2022

Recurrent respiratory papillomatosis (RRP) is a condition characterized by the repeated growth of benign exophytic papillomata in [...]

How Enhancing Immunity to Low-Risk HPV Could Cure Recurrent Respiratory Papillomatosis
30 September 2022

Recurrent respiratory papillomatosis (RRP) is currently treated with repeat surgical resection of papillomatous disease that [...]

  • 1
  • 2
RRP Africa is a non-profit organisation committed to enhancing the quality of life and medical care for RRP patients and the ultimate eradication of RRP in Africa.
Copyright 2025 © RRP Africa. Website by Quickfox Publishing
  • Home
  • Pledge-a-thon
  • Practitioners
  • FAQ
  • Contact us
  • Login
Pledge your support!

If you opt in, we use this information to send you related content and RRP updates.

Login

Lost your password?